The Park Novum inaugurated!
On November 5, the doors to The Park Novum opened – a new co-working space in Novum Research Park. The festivities came with a Halloween theme, and gathered over 150 participants who celebrated together.
Together for the medicine of the future – Karolinska ATMP Centre and ATMP Centre Uppsala strengthens collaboration in advanced therapies
A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint kick-off at the end of October, where hopes for new research breakthroughs and benefits for patients were in focus.
A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated
With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.
Touchdown Novum Labs for Hydromars!
A new company has arrived in Flemingsberg, and they´re moving at rocket speed on their journey toward space. Meet Hydromars, the startup company developing a system for water purification and nutrient recovery, with a grand goal of enabling sustainable human presence in space.
ATMP Sweden – now also in Flemingsberg!
The ATMP Sweden association carries out dedicated work focused on national coordination and communication to accelerate the development, accessibility, and implementation of advanced therapies (ATMP). And now they also have an office space at Novum Labs! From here, Henrik Simonsson, Communications and Operative Lead, can work on the association’s plans to take its operations to even more meaningful heights.
AlzeCure Pharma – a hope in the fight against Alzheimer’s
Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.
Kick-off Cluster Engine Life Science Flemingsberg!
At the end of last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund (ERDF) for the project Cluster Engine Life Science Flemingsberg, which aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. Recently, it was time for the official launch – and what a grand launch it was!